On May 6, 2021, plaintiffs sued defendants for patent infringement in the United States District Court for the District of Delaware.  The parties are biotechnology companies and competitors that offer tools for studying genetic material on a cellular level, including competing sequencing-based tools for performing spatial analyses of biological molecules.